BridgeMD
New treatment option for Long-acting Injectable Cabotegravir for PrEP
Official title BetterInfo on Women's PrEP Choices and Outcomes in Malawi
ClinicalTrials.gov ID: NCT07579754
What this study is testing
- What it's testing
- The purpose of this study is to understand PrEP user choices, preferences and implementation impact of the roll-out of long-acting injectable PrEP alongside oral PrEP among women in Blantyre, Malawi.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 110, women only. Healthy volunteers may be eligible.
You may be able to join if
- The population for this research includes women aged 18 years or older at risk of HIV who initiated injectable or oral PrEP at one of the 20 Blantyre...
- Adult women ≥18 years; and
- Initiated PrEP (injectable or oral) at the implementing facilities and lost to follow up within prior 2 years prior to sampling; and
- Lost-to-follow-up (missed their PrEP visit by ≥3 months and for whom outcomes are unknown); and
- Has a registered phone number for contact Those eligible for tracing are as follows:
You likely can't join if
- Those excluded from sampling or tracing include:
- Women who have an EMR record of a documented case of discontinuation of PrEP in consultation with a provider; or
- Women who are known to have died; or
- Women who have EMR documented transfers out of PathToScale supported facilities; or
- Women refusing follow-up via phone on their ScanForm; or
- Women refusing follow-up in person (during phone tracing); or
See the full eligibility criteria
- The population for this research includes women aged 18 years or older at risk of HIV who initiated injectable or oral PrEP at one of the 20 Blantyre sites supported through PathToScale. PathToScale supports various...
- Adult women ≥18 years; and
- Initiated PrEP (injectable or oral) at the implementing facilities and lost to follow up within prior 2 years prior to sampling; and
- Lost-to-follow-up (missed their PrEP visit by ≥3 months and for whom outcomes are unknown); and
- Has a registered phone number for contact Those eligible for tracing are as follows:
- Women sampled per eligibility criteria above; and
- Women who have indicated permission for in-person follow-up Health Care Providers, Implementing Partners, Ministry of Health (MOH) Stakeholers
- providers and implementing partners from PathtoScale, and Ministry of Health stakeholders will be consented to participate in in-depth-interviews
- Those excluded from sampling or tracing include:
- Women who have an EMR record of a documented case of discontinuation of PrEP in consultation with a provider; or
- Women who are known to have died; or
- Women who have EMR documented transfers out of PathToScale supported facilities; or
- Women refusing follow-up via phone on their ScanForm; or
- Women refusing follow-up in person (during phone tracing); or
- Women who do not speak Chichewa or English; or
- Men (excluded from client interviews only)
The study team makes the final eligibility decision.
Where it's taking place
- Blantyre, Malawi
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 110 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Blantyre, Malawi. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.